New Biomaterials for Therapy

  • Author/Organiser: Israel Chemical Society
  • Event Website:
  • Event Date: 07 May 2013
  • Event Type: Conference
  • Venue: Ben-Gurion University of the Negev,, Beer-Sheva, Israel

View Full Event Details

Israel Chemical Society symposium in honor of the 2013 Wolf Prize Laureate Robert Langer.

Speakers and Topics:

  • Mr. Alan Crane,
    General Partner, Polaris Venture Partners, Waltham, MA, USA
    Robert Langer and the transformation of innovation
  • Craig Wheeler and Dr. Ganesh Kaundinya
    Momenta Pharmaceuticals, Inc. Cambridge, MA, USA
    Embracing complexity: the story of momenta pharmaceuticals
  • Ram Sasisekharan,
    Koch Institute for Integrative Cancer Research, Department of Biological Engineering, MIT, Boston, MA, USA
    Sweet Science and Robert Langer
  • Prof. Shulamit Levenberg,
    Department of Biomedical Engineering, Technion – Israel Institute of Technology
    Bioactive scaffolds for vascularization of engineered tissues
  • Prof. Smadar Cohen,
    Department of Biotechnology Engineering, Ben-Gurion University of the Negev
    Engineering Biomaterials for Myocardial Regeneration and Repair
  • Prof. Avi Domb,
    School of Pharmacy, The Hebrew University of Jerusalem
    The successful story of hydroxy acid biopolymers
  • Prof. Michael V. Sefton,
    Department of Chemical Engineering and Applied Chemistry, University of Toronto, Canada
    Vascularized Tissue Engineering and Regenerative Biomaterials
  • Prof. Yosi Kost,
    Dean of Engineering Sciences, Ben-Gurion University of the Negev
    Stimuli Responsive Delivery of Therapeutics
  • Prof. Avi Schroeder,
    Department of Chemical Engineering, Technion – Israel Institute of Technology
    Integrating molecular machines into nano therapeutics
  • Molly Shoichet,
    Department of Chemical Engineering & Applied Chemistry, Chemistry and Biomaterials & Biomedical Engineering, University of Toronto, Canada
    Cell and Drug Delivery Strategies in the Central Nervous System
  • Prof. Robert Langer, Departments of Chemical Engineering and Biological Engineering, MIT.
    Biomaterials and biotechnology: from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering

Article Views: 1691

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

Magazine of Chemistry Europe (16 European Chemical Societies)published by Wiley-VCH